Why Was the Azithromycin “for Life” Trial Necessary?

In 2009, a cluster-randomized trial showed a 49% reduction in all-cause mortality among Ethiopian children 1 to 9 years of age in the year after mass distribution of a single dose of azithromycin for trachoma prevention — a reduction that was sustained over the following 26 months.1 This…

​   The New England Journal of Medicine: Search Results in Pediatrics